SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 12th, 2023 • GENELUX Corp • Pharmaceutical preparations • New York
Contract Type FiledJune 12th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of June 9, 2023, is made by and among Genelux Corporation, a Delaware corporation (the “Company”), and the Purchasers listed on the signature pages hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 13th, 2023 • Regulus Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 13th, 2023 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of April 13, 2023, is made by and among REGULUS THERAPEUTICS INC., a Delaware corporation (the “Company”), and the Purchasers listed on Exhibit A hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 29th, 2022 • Anebulo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 29th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of September 25, 2022, is made by and among Anebulo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the Purchasers listed on Exhibit A hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 30th, 2021 • Regulus Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 30th, 2021 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 24, 2021, is made by and among REGULUS THERAPEUTICS INC., a Delaware corporation (the “Company”), and the Purchasers listed on Exhibit A hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 4th, 2020 • Regulus Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 4th, 2020 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of December 1, 2020, is made by and among REGULUS THERAPEUTICS INC., a Delaware corporation (the “Company”), and the Purchasers listed on Exhibit A hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 16th, 2011 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 16th, 2011 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 11, 2011, is made by and among BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and the Purchasers listed on Exhibit A hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”).